• Denali CEO to open AAIC 2026 with brain-delivery plan for Alzheimer’s Stock Titan Thu, 09 Jul 2026 20:01:00 GMT
• T. Rowe Price’s 10% Stake and Avlayah Approval Could Be A Game Changer For Denali Therapeutics (DNLI) simplywall.st Thu, 09 Jul 2026 11:40:52 GMT
• DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth? Yahoo Finance Wed, 08 Jul 2026 18:05:00 GMT
• T. Rowe Price holds 10.2% of Denali Therapeutics (DNLI) in 13G/A Stock Titan Wed, 08 Jul 2026 15:30:48 GMT
• Amyotrophic Lateral Sclerosis Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Helixmith, Sanofi, Den... Barchart.com Tue, 07 Jul 2026 00:30:21 GMT
• Denali Therapeutics (DNLI) Looks Fully Valued Following Its 32% 30 Day Rally Sahm Sun, 05 Jul 2026 07:00:00 GMT
• denali therapeutics stock stays focused on pipeline progress. AD HOC NEWS Fri, 03 Jul 2026 18:03:20 GMT
• Amyotrophic Lateral Sclerosis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight | Heli... Barchart.com Wed, 01 Jul 2026 13:34:17 GMT
• Enterprise value to EBIT forward of Denali Therapeutics Inc. – NASDAQ:DNLI TradingView Sat, 27 Jun 2026 23:38:38 GMT
• denali therapeutics inc (dnli) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 04:00:34 GMT
• denali therapeutics inc shs unsponsored brazilian depositary receipt repr 0.2 sh TradingView Sat, 27 Jun 2026 01:44:51 GMT
• denali therapeutics inc. actuals & estimates (nasdaq:dnli) TradingView Fri, 26 Jun 2026 20:40:05 GMT
• Enterprise value to EBITDA forward of Denali Therapeutics Inc. – NASDAQ:DNLI TradingView Fri, 26 Jun 2026 19:12:40 GMT
• How Denali Therapeutics Inc. (DNLI) Affects Rotational Strategy Timing Stock Traders Daily Thu, 25 Jun 2026 20:30:01 GMT
• Denali Therapeutics stock hits 52-week high at 25.74 USD By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 18:45:22 GMT
• We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate Moomoo Thu, 25 Jun 2026 12:41:31 GMT
• Denali Therapeutics options trading jumps to 2,291 contracts Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) looks fully valued after $195 million voucher sale simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• denali therapeutics sells rare pediatric disease priority review voucher for $195 million Global Legal Chronicle Wed, 24 Jun 2026 00:00:00 GMT
• regenxbio shares rise on plans to resubmit navsunli bla for mps ii Yahoo Finance Tue, 23 Jun 2026 14:46:00 GMT
• firm advises denali therapeutics on agreement to sell rare pediatric disease priority review voucher for $195 million Wilson Sonsini Mon, 22 Jun 2026 20:46:18 GMT
• stifel reiterates buy rating on denali stock, cites launch progress by investing.com Investing.com India Mon, 22 Jun 2026 14:29:14 GMT
• in another reversal for rare disease field, fda to reconsider regenxbio gene therapy Fierce Biotech Mon, 22 Jun 2026 14:26:41 GMT
• Stifel reiterates Buy rating on Denali Therapeutics stock at $41 Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Why Denali Therapeutics (DNLI) Is Up 8.2% After Selling Its Priority Review Voucher For $195 Million simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• exclusive bac article: denali therapeutics; fda approval avlayah for mps ii, potential accelerated approval bla for mps iiia 2027,... Seeking Alpha Mon, 22 Jun 2026 07:00:00 GMT
• denali sells fda voucher for $195m to support neurodegenerative pipeline BioSpace Fri, 19 Jun 2026 14:38:09 GMT
• Denali to Sell Priority Review Voucher for $195M Cash Boost TradingView Fri, 19 Jun 2026 12:40:00 GMT
• Denali Monetizes Rare Pediatric Disease Voucher In $195m Deal After Avlayah FDA Nod insights.citeline.com Fri, 19 Jun 2026 07:00:00 GMT
• denali therapeutics inc (dnli) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 12:53:56 GMT
• denali sells rare pediatric disease priority review voucher for $195m to fund neurodegenerative drug development. Pluang Thu, 18 Jun 2026 12:45:02 GMT
• denali therapeutics enters agreement to sell rare pediatric disease priority review voucher for $195 million The Manila Times Thu, 18 Jun 2026 12:15:49 GMT
• denali therapeutics stock hits 52-week high at 23.78 usd by investing.com Investing.com Nigeria Thu, 18 Jun 2026 10:47:04 GMT
• Denali Therapeutics (Nasdaq: DNLI) to sell pediatric priority review voucher for $195M Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Denali Therapeutics to Sell FDA Priority Review Voucher for $195 Million TradingView Thu, 18 Jun 2026 07:00:00 GMT
• Denali Therapeutics to sell priority review voucher for $195m Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Denali Therapeutics: FDA Awarded PRV Following Accelerated Approval of Enzyme Replacement Therapy AVLAYAH for Treatment of Hunter ... Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• Pfizer CFO to step down; Denali sells a regulatory fast-pass Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• Denali’s rare disease voucher sale brings in $195 million Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• denali to sell priority review voucher for $195m (dnli:nasdaq) Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• an undisclosed buyer entered into an asset purchase agreement to acquire rare pediatric disease priority review voucher of denali ... marketscreener.com Wed, 17 Jun 2026 22:00:00 GMT
• denali therapeutics inc (dnli) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:04:54 GMT
• denali therapeutics inc (dnli) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 20:53:53 GMT
• transcript : denali therapeutics inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-09-2026 01 marketscreener.com Wed, 17 Jun 2026 09:10:16 GMT
• Denali Therapeutics stock hits 52-week high at 23.78 USD Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Denali Therapeutics (DNLI) Receives a Buy from UBS The Globe and Mail Wed, 17 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) q1 2026 earnings: narrower-than-expected loss as pipeline advances - dividend growth analysis newsline.com Tue, 16 Jun 2026 07:46:48 GMT
• UBS reiterates Denali Therapeutics stock rating citing Avlayah launch Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• ubs maintains denali therapeutics(dnli.us) with buy rating, maintains target price $25 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• denali therapeutics inc (dnli) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• denali therapeutics inc (dnli) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• denali therapeutics inc (dnli) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• denali therapeutics inc (dnli) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• (dnli) and the role of price-sensitive allocations Stock Traders Daily Sun, 14 Jun 2026 19:18:02 GMT
• denali therapeutics (dnli) stock valuation after setback in luma trial and focus on beacon study Sahm Sat, 13 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) rallies over 3% as stock tests key resistance levels - stock analysis newsline.com Fri, 12 Jun 2026 14:41:13 GMT
• should denali’s pivot to beacon precision trial after biib122 setback require action from denali (dnli) investors? simplywall.st Fri, 12 Jun 2026 07:00:00 GMT
• What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names Yahoo Finance Thu, 11 Jun 2026 07:00:00 GMT
• lrrk2 inhibitor failure pushes parkinson’s field toward genetic enrichment biocentury.com Wed, 10 Jun 2026 22:36:00 GMT
• denali therapeutics (dnli) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Tue, 09 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) director granted rsus and options in new award Stock Titan Fri, 05 Jun 2026 20:45:59 GMT
• denali therapeutics (dnli) director receives rsu and stock option awards Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• director at denali therapeutics (nasdaq: dnli) receives rsus and options Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) grants rsus and stock options to director Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• denali therapeutics (nasdaq: dnli) details baker rsu and stock option grants Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• denali therapeutics (dnli) director receives new rsu and stock option grants Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Denali Therapeutics (DNLI) 2026 meeting backs board slate, auditor and executive pay Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• denali stock dips as biogen-partnered parkinson's disease study fails MSN Wed, 03 Jun 2026 17:34:15 GMT
• getting alzheimer’s drugs into the brain is hard. now there’s a new trick. Barron's Wed, 03 Jun 2026 07:30:00 GMT
• denali therapeutics (dnli) 2026 meeting backs board slate, auditor and executive pay Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• biogen ends biib122 parkinsons trial and refocuses neurodegeneration pipeline Yahoo Finance Tue, 02 Jun 2026 10:07:31 GMT
• does denali therapeutics (dnli) parkinson’s setback reveal a deeper shift in its neuroscience strategy? simplywall.st Mon, 01 Jun 2026 17:16:01 GMT
• Denali Therapeutics Inc. (DNLI): One of the Top Stock Picks of Jeff Bezos Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• dnli stock price, quote & chart | denali therapeutics inc (nasdaq:dnli) ChartMill Mon, 01 Jun 2026 07:00:00 GMT
• dnli earning date, earning analysis and earning prediction Intellectia AI Sun, 31 May 2026 14:56:14 GMT
• a look at denali therapeutics (dnli) valuation after phase 2b trial failure refocuses attention on its pipeline Sahm Sat, 30 May 2026 16:03:06 GMT
• denali therapeutics says avlayah launch ahead of expectations after hunter syndrome approval MSN Sat, 30 May 2026 12:17:47 GMT
• Biogen and Denali halt BIIB122 trial for idiopathic Parkinson’s Parkinson's News Today Fri, 29 May 2026 07:00:00 GMT
• a look at denali therapeutics (dnli) valuation after phase 2b trial failure refocuses attention on its pipeline simplywall.st Fri, 29 May 2026 07:00:00 GMT
• dnli stock price, quote & chart | denali therapeutics inc (nasdaq:dnli) ChartMill Fri, 29 May 2026 07:00:00 GMT
• denali stock dips as biogen-partnered parkinson's disease study fails MSN Thu, 28 May 2026 01:13:07 GMT
• denali therapeutics says avlayah launch ahead of expectations after hunter syndrome approval MSN Wed, 27 May 2026 22:33:57 GMT
• denali stock dips as biogen-partnered parkinson's disease study fails MSN Wed, 27 May 2026 10:47:46 GMT
• Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN Data Seeking Alpha Wed, 27 May 2026 07:00:00 GMT
• dnli maintained by morgan stanley -- price target lowered to $35 GuruFocus Tue, 26 May 2026 18:33:45 GMT
• a quick look at today's ratings for denali therapeutics(dnli.us), with a forecast between $31 to $42 富途牛牛 Tue, 26 May 2026 10:36:09 GMT
• denali therapeutics' focus shifts to other pipeline assets after phase 2b study failure, morgan stanley says marketscreener.com Tue, 26 May 2026 07:00:00 GMT
• biogen, denali scrap parkinson's drug after failure in mid-to-late stage study ETPharma.com Tue, 26 May 2026 01:54:46 GMT
• privium fund opens $5.07 million denali stake ahead of fda drug approval AOL.com Mon, 25 May 2026 10:14:11 GMT
• biogen and denali discontinue parkinson’s candidate biib122 after phase iib luma study miss Manufacturing Chemist Mon, 25 May 2026 07:05:27 GMT
• biogen, denali to drop parkinson’s therapy after mid-stage trial setback MSN Sun, 24 May 2026 17:23:47 GMT
• denali stock dips as biogen-partnered parkinson's disease study fails MSN Sun, 24 May 2026 11:03:05 GMT
• analysts are bullish on top healthcare stocks: denali therapeutics (dnli), intuitive surgical (isrg) The Globe and Mail Sat, 23 May 2026 07:00:00 GMT
• a quick look at today's ratings for denali therapeutics(dnli.us), with a forecast between $31 to $42 Moomoo Sat, 23 May 2026 07:00:00 GMT
• is early avlayah demand reshaping the investment case for denali therapeutics’ rare-disease platform (dnli)? Sahm Fri, 22 May 2026 20:16:49 GMT
• morgan stanley cuts price target on denali therapeutics to $35 from $40, keeps overweight rating Moomoo Fri, 22 May 2026 18:31:23 GMT
• h.c. wainwright maintains denali therapeutics(dnli.us) with buy rating, maintains target price $42 Moomoo Fri, 22 May 2026 12:33:00 GMT
• biogen (biib) and denali (dnli) halt development of biib122 afte GuruFocus Fri, 22 May 2026 12:30:53 GMT
• denali therapeutics: buy rating reiterated as tv platform and enzyme portfolio drive long-term upside; $42 price target maintained... TipRanks Fri, 22 May 2026 12:10:42 GMT
• wedbush cuts price target on denali therapeutics to $20 from $23, keeps outperform rating Moomoo Fri, 22 May 2026 11:59:56 GMT
• deutsche bank adjusts denali therapeutics price target to $31 from $35, maintains buy rating Moomoo Fri, 22 May 2026 11:49:33 GMT
• biogen, denali to drop parkinson’s therapy (biib:nasdaq) Seeking Alpha Fri, 22 May 2026 11:01:46 GMT
• biogen axes denali-partnered parkinson’s drug after phase 2 flop Fierce Biotech Fri, 22 May 2026 10:12:01 GMT
• biogen, denali pull parkinson's drug after failed trial pharmaphorum Fri, 22 May 2026 07:51:22 GMT
• Biogen and Denali report Phase IIb LUMA trial data for Parkinson’s Clinical Trials Arena Fri, 22 May 2026 07:00:00 GMT
• Biogen, Denali pull plug on Parkinson’s program after mid-stage flop BioSpace Fri, 22 May 2026 07:00:00 GMT
• Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails Yahoo Finance Fri, 22 May 2026 07:00:00 GMT
• Biogen, Denali axe LRRK2 inhibitor in idiopathic Parkinson’s after mid-stage miss FirstWord Pharma Fri, 22 May 2026 07:00:00 GMT
• Biogen, Denali to drop Parkinson’s therapy after mid-stage trial setback Seeking Alpha Fri, 22 May 2026 07:00:00 GMT
• biogen axes denali-partnered parkinson’s prospect after phase 2 flop Fierce Biotech Fri, 22 May 2026 07:00:00 GMT
• denali therapeutics stock falls after parkinson’s drug fails trial Investing.com Fri, 22 May 2026 07:00:00 GMT
• biogen, denali to drop drug in non-genetic parkinson’s after mid-stage study flop Endpoints News Fri, 22 May 2026 07:00:00 GMT
• denali therapeutics and biogen discontinue biib122 after phase 2b luma misses endpoints TradingView Fri, 22 May 2026 07:00:00 GMT
• biogen and denali therapeutics provide update on phase 2b luma study of biib122 (dnl151) in early-stage parkinson’s disease Sahm Fri, 22 May 2026 07:00:00 GMT
• biogen, denali scrap parkinson’s candidate after phase iib miss The Pharma Letter Fri, 22 May 2026 07:00:00 GMT
• dnli stock price, quote & chart | denali therapeutics inc (nasdaq:dnli) ChartMill Fri, 22 May 2026 07:00:00 GMT
• biogen, denali scrap parkinson’s drug after failure in mid-to-late stage study 1470 & 100.3 WMBD Fri, 22 May 2026 05:20:31 GMT
• biogen, denali scrap parkinson's drug after failure in mid-to-late stage study AOL.com Fri, 22 May 2026 03:14:29 GMT
• parkinson’s trial setback: biogen, denali halt biib122 program, await 2027 data Stock Titan Fri, 22 May 2026 02:46:59 GMT
• biogen and denali therapeutics halt biib122 development after tr GuruFocus Fri, 22 May 2026 01:02:32 GMT
• biogen and denali therapeutics halt biib122 development after tr GuruFocus Thu, 21 May 2026 23:55:53 GMT
• biib, dnli stocks edge lower after hours: parkinson’s drug misses key goals in trial Yahoo Finance Thu, 21 May 2026 23:03:49 GMT
• biogen (biib) halts development of biib122 after phase 2b study results GuruFocus Thu, 21 May 2026 22:35:28 GMT
• biogen, denali discontinue parkinson’s drug after trial fails by investing.com Investing.com Australia Thu, 21 May 2026 22:33:07 GMT
• biogen, denali scrap parkinson’s drug after failure in mid-to-late stage study WTAQ Thu, 21 May 2026 22:26:16 GMT
• is early avlayah demand reshaping the investment case for denali therapeutics’ rare-disease platform (dnli)? simplywall.st Thu, 21 May 2026 15:55:23 GMT
• Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease Biogen Thu, 21 May 2026 07:00:00 GMT
• Biogen, Denali scrap Parkinson's drug after failure in mid-to-late stage study Reuters Thu, 21 May 2026 07:00:00 GMT
• Parkinson’s trial setback: Biogen, Denali halt BIIB122 program, await 2027 data Stock Titan Thu, 21 May 2026 07:00:00 GMT
• Closely watched experimental Parkinson’s drug fails key clinical trial STAT Thu, 21 May 2026 07:00:00 GMT
• dnli stock price, quote & chart | denali therapeutics inc (nasdaq:dnli) ChartMill Thu, 21 May 2026 07:00:00 GMT
• takeda exits dementia drug partnership with denali therapeutics - here's why MSN Wed, 20 May 2026 05:41:17 GMT
Denali Therapeutics Inc(NASDAQ:DNLI) 
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 that has completed Phase 1b clinical trials...
Website: http://www.denalitherapeutics.com
Founded: 2013
Full Time Employees: 281
Sector: Healthcare
Industry: Biotechnology